High materiality7/10
H.C. Wainwright Reiterates Buy Rating on SpyGlass Pharma (SGP)
Why it may matterVerify against the original reporting
Reiterated Buy; bullish setup
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates Buy; target $37; price $24.92; upside ~49%.
- Target $37; price $24.92; upside ~49%
- Rating: Buy (reiterated)
Key facts
- 01
Target: $37
- 02
Posted price: $24.92
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Yi Chen
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.